The overall survival rate of HCC patients with high expression of lncRNA FEZF1-AS1 was significantly decreased [12], while the overall survival rate of LUAD patients with high expression of lncRNA ENST0000630242 was increased [41]. This evidence concerns the gene FEZF1 and hepatocellular carcinoma.